SCHEMBL7734705

SCHEMBL7734705

O=C(Cc1ccccc1)Nc1cc(Cl)ccc1O

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.74
ALOX15 P16050 1/20 0.74
POLB P06746 1/20 0.69
MEN1 O00255 4/20 0.69
KMT2A Q03164 4/20 0.69
L3MBTL1 Q9Y468 3/20 0.69
LMNA P02545 1/20 0.62
GAA P10253 1/20 0.62
KCNMA1 Q12791 7/20 0.61
STAT3 P40763 1/20 0.58
HPGD P15428 2/20 0.55
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA5A P35218 1/20 0.54
CA7 P43166 1/20 0.54
CA5B Q9Y2D0 1/20 0.54
ALDH1A1 P00352 1/20 0.54
PKM P14618 1/20 0.54
TSHR P16473 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1308597 0.84 MEN1 (0.72) MAPK1MEN1KMT2AL3MBTL1LMNA
SCHEMBL8925483 0.82 HPGD (0.68) MAPK1ALOX15MEN1KMT2AL3MBTL1
SCHEMBL7736629 0.82 MEN1 (0.70) MAPK1ALOX15POLBMEN1KMT2A
SCHEMBL5144511 0.82 POLB (0.86) MAPK1ALOX15POLBMEN1KMT2A
SCHEMBL29354065 0.82 CA1 (0.54) MAPK1ALOX15MEN1KMT2AL3MBTL1
SCHEMBL554401 0.82 CA1 (0.54) MAPK1ALOX15MEN1KMT2AL3MBTL1
SCHEMBL8370324 0.82 NTRK1 (0.63) MAPK1ALOX15POLBMEN1KMT2A
SCHEMBL8924485 0.81 L3MBTL1 (0.61) MAPK1ALOX15MEN1KMT2AL3MBTL1
SCHEMBL4352857 0.81 MEN1 (0.59) MAPK1ALOX15POLBMEN1KMT2A
SCHEMBL29511368 0.80 HPGD (0.67) MEN1KMT2AL3MBTL1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6372770-B1 TREATING A MAMMAL SUFFERING FROM A DISEASE STATE SELECTED FROM THE GROUP CONSISTING OF ASTHMA, ALLERGIES, INFLAMMATION, DEPRESSION, DEMENTIA, ATOPIC DISEASES, RHINITIS AND DISEASE STATES ASSOCIATED WITH ABNORMALLY HIGH PHYSIOLOGICAL LEVELS OF EURO-CELTIQUE, S.A. 2002-04-16 US disclosed
EP-0785927-A4 NOVEL BENZOXAZOLES EURO CELTIQUE SA (LU) 1997-12-29 EP disclosed
EP-0785927-A1 NOVEL BENZOXAZOLES Euroceltique S.A. (LU) 1997-07-30 EP disclosed
WO-1996011917-A1 NOVEL BENZOXAZOLES EURO-CELTIQUE, S.A. (LU) 1996-04-25 WO disclosed